Cargando…
Association Between Metabolic-Associated Fatty Liver Disease and Obstructive Sleep Apnea: A Cross-Sectional Study
AIM: Emerging evidence has revealed that obstructive sleep apnea (OSA) is an independent risk factor for the development of a variety of adverse metabolic disease states. In this study, we evaluated the association between OSA severity and metabolic dysfunction-associated fatty liver disease (MAFLD)...
Autores principales: | Huang, Jiefeng, Chen, Lida, Li, Xiuling, Chen, Menglan, Lin, Ting, Chen, Gongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985450/ https://www.ncbi.nlm.nih.gov/pubmed/36879664 http://dx.doi.org/10.2147/NSS.S398971 |
Ejemplares similares
-
Risk Factors of Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Non-Obese Patients with Obstructive Sleep Apnea
por: Lian, Ningfang, et al.
Publicado: (2022) -
Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apnea
por: Chung, Goh Eun, et al.
Publicado: (2021) -
Association of Obstructive Sleep Apnea with Nocturnal Hypoxemia in Metabolic-Associated Fatty Liver Disease Patients: A Cross-sectional Analysis of Record-based Data
por: Tomar, Arvind, et al.
Publicado: (2021) -
The association between glycometabolism and nonalcoholic fatty liver disease in patients with obstructive sleep apnea
por: Ding, Haibo, et al.
Publicado: (2018) -
Association of Hypertriglyceridemic Waist Phenotype with Obstructive Sleep Apnea: A Cross-Sectional Study
por: Gu, Meizhen, et al.
Publicado: (2021)